CHM Price sensitive 13 Nov 2025, 10:22 AM

75% disease control observed in CHM CDH17 trial

Chimeric Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in